Novo Nordisk A/SNVONYSE
Loading
Revenue Growth Under PressureDecelerating
Percentile Rank14
3Y CAGR-55.0%
5Y CAGR-10.3%
Year-over-Year Change
Year-over-year revenue growth rate
3Y CAGR
-55.0%/yr
vs +281.8%/yr prior
5Y CAGR
-10.3%/yr
Recent deceleration
Acceleration
-336.8pp
Decelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
2 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 2.34% |
| 2024 | 25.03% |
| 2023 | 31.26% |
| 2022 | 25.68% |
| 2021 | 10.91% |
| 2020 | 4.04% |
| 2019 | 9.11% |
| 2018 | 0.12% |
| 2017 | -0.08% |
| 2016 | 3.57% |